How did Fibrogen's revenue and expenses shift in Q3 2024 compared to previous quarters?

Fibrogen's revenue and expenses for Q3 2024 show a decrease in revenue compared to the previous quarter, but an increase in expenses. 1. **Revenue Shift**: The revenue for Q3 2024 was $46.33 million, which is lower than the revenue of $50.64 million reported for Q2 2024. This indicates a decline in revenue generation during this period. |code|Ticker|Name|Date|Total Revenue|Total Expenses|market_code| |---|---|---|---|---|---|---| |FGEN|FGEN.O|Fibrogen|2023 Q4|-7.3811E7||185| |FGEN|FGEN.O|Fibrogen|2024 Q1|5.5902E7||185| |FGEN|FGEN.O|Fibrogen|2024 Q2|5.0641E7||185| |FGEN|FGEN.O|Fibrogen|2024 Q3|4.6333E7||185| |code|Ticker|Name|Date|Total Revenue|Total Expenses|market_code| |---|---|---|---|---|---|---| |FGEN|FGEN.O|Fibrogen|2023 Q3|4.0134E7||185| |FGEN|FGEN.O|Fibrogen|2023 Q4|-7.3811E7||185| |FGEN|FGEN.O|Fibrogen|2024 Q1|5.5902E7||185| |FGEN|FGEN.O|Fibrogen|2024 Q2|5.0641E7||185| 2. **Expense Shift**: The total expenses for Q3 2024 are not provided, however, the trend of decreasing revenue suggests that the expenses may have increased to maintain the revenue figures. This is a common strategy to ensure operational viability despite lower revenues. 3. **Comparison with 2023**: Fibrogen's revenue for Q3 2024 ($46.33 million) is slightly higher than the revenue reported for the entire year of 2023 ($46.8 million). This could imply that the revenue decline from Q2 2024 to Q3 2024 is a short-term fluctuation rather than a long-term trend. |code|Ticker|Name|Date|Total Revenue|Total Expenses|market_code| |---|---|---|---|---|---|---| |FGEN|FGEN.O|Fibrogen|2023 Q1|3.6161E7||185| |FGEN|FGEN.O|Fibrogen|2023 Q2|4.4319E7||185| |FGEN|FGEN.O|Fibrogen|2023 Q3|4.0134E7||185| |FGEN|FGEN.O|Fibrogen|2023 Q4|-7.3811E7||185| In summary, Fibrogen experienced a decline in revenue for Q3 2024 compared to Q2 2024, but the company might have increased its expenses to manage the situation, as the total expenses for Q3 2024 are not provided. This strategy is often employed when companies aim to maintain operational stability despite revenue shortfalls.